USD10
ONC Ações
Sobre BeOne MedicinesBeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
USD10
ONC Ações
Sobre BeOne MedicinesBeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.
Estatísticas
JANELA DE NEGOCIAÇÃO
Aberta
ENCERRA ÀS
20:00 GMT+0
CAPITALIZAÇÃO DE MERCADO
US$ 30,52 bi
PREÇO ABERTO
US$ 273,95
BAIXO (1 A)
US$ 196,45
ALTO (1 A)
US$ 385,22
BAIXO (24H)
US$ 273,50
ALTO (24H)
US$ 279,25
VOLUME (24H)
US$ 107,18 mil
55,05%
Histórico de preços
Time | Price | Change |
|---|---|---|
Hoje | US$ 273,95 | |
1 dia | US$ 270,69 | |
1 semana | US$ 288,75 | |
1 mês | US$ 365,93 | |
1 ano | US$ 253,20 |